Co-Founder, Professor Guoping Feng (MIT/Broad) Inducted into the National Academy of Medicines

Medford MA, October 10, 2023 – Professor Guoping Feng, a distinguished neuroscientist known for his groundbreaking research in the fields of neurobiology and genetics, has been elected as a member of the prestigious National Academy of Medicines (NAM). The induction recognizes his significant contributions to the scientific, medical, and patient community and his outstanding achievements in the field of neuroscience.

Professor Feng is an internationally renowned expert in the field of neural transgenic animal models and one of the pioneers in optogenetics research. He focuses on studying the synaptic and circuit functions, as well as the pathogenesis of neurological disorders, contributing to the development of new technologies for neuroscience research. His work has systematically revealed the developmental mechanisms of acetylcholine-sensitive neuronal synapses. Additionally, he created a green fluorescent protein transgenic mouse model widely used in the neuroscience community. In 2019, he was elected as a Fellow of the American Academy of Arts and Sciences.

The National Academy of Medicine, established in 1970, operates independently of the U.S. government and provides objective advice on science and health to the public, decision-makers, and leaders across various industries. It is one of the four prestigious academic institutions in the United States, alongside the National Academy of Sciences, the National Academy of Engineering, and the National Science Foundation. Members of the National Academy of Medicine hold lifetime positions and play a crucial role in offering guidance to the U.S. government on matters related to consultation, prevention, and engage in global health affairs.